Redx Pharma (REDX) RNS Announcements

Add to Alert list
Date Time Source Announcement
16 Mar 2020 05:31 PM
RNS
Holding(s) in Company
16 Mar 2020 05:30 PM
RNS
Holding(s) in Company
13 Mar 2020 07:37 AM
RNS
Holdings in Company
13 Mar 2020 07:00 AM
RNS
Confirmation of Private Approach
11 Mar 2020 07:00 AM
RNS
Final Results for Year Ended 30 September 2019
09 Mar 2020 10:05 AM
RNS
Holding(s) in Company
02 Mar 2020 07:00 AM
RNS
Re-release: Funding Update
28 Feb 2020 06:29 PM
RNS
Funding update
28 Feb 2020 05:56 PM
RNS
Termination of discussions with Yesod Bio-Sciences
14 Feb 2020 04:16 PM
RNS
Further statement re Rule 2.6 Extension
28 Jan 2020 07:00 AM
RNS
Statement re Rule 2.6 Extension
24 Jan 2020 11:05 AM
RNS
Holding(s) in Company
24 Jan 2020 09:40 AM
RNS
Holding(s) in Company
22 Jan 2020 05:04 PM
RNS
Paul John Blackmore - Form 8.3 - RedX Pharma
21 Jan 2020 01:23 PM
RNS
Result of General Meeting
09 Jan 2020 02:14 PM
RNS
Public Opening Position Disclosure
09 Jan 2020 07:00 AM
RNS
RXC007 nominated as drug development candidate
03 Jan 2020 04:14 PM
RNS
Posting of Circular to Shareholders
31 Dec 2019 07:00 AM
RNS
Loan Capitalisation, GM Notice and Possible Offer
19 Nov 2019 07:00 AM
RNS
Redx & Medicines Discovery Catapult awarded grant
07 Nov 2019 03:30 PM
RNS
Holding(s) in Company
23 Sep 2019 07:00 AM
RNS
RXC006 poster presentation at ERS Congress
19 Aug 2019 07:00 AM
RNS
First cohort of patients dosed in RXC004 study
18 Jul 2019 10:23 AM
EQS
RedX Pharma (REDX): Pan-RAF agreement strengthe...
11 Jul 2019 01:40 PM
EQS
Redx Pharma (REDX): Phase I trial resumed
10 Jul 2019 07:00 AM
RNS
Sale of pan-RAF inhibitor programme
10 Jun 2019 07:01 AM
RNS
Interim Results for six months ended 31 March 2019
10 Jun 2019 07:00 AM
RNS
Short-term Debt Funding Secured
03 May 2019 11:34 AM
RNS
Update on Plans to Strengthen Balance Sheet
29 Mar 2019 07:00 AM
RNS
Redx to present two posters at AACR 2019
28 Feb 2019 07:00 AM
RNS
Issue of Warrants and Change to Lease Agreement
14 Feb 2019 07:00 AM
RNS
Directorate Update
12 Feb 2019 07:00 AM
RNS
New in vivo data on ROCK2
06 Feb 2019 11:25 AM
RNS
Receipt of Outstanding Loan
31 Jan 2019 07:00 AM
RNS
Deinove return rights to Redx Programme
23 Jan 2019 11:25 AM
RNS
Results of Annual General Meeting
21 Jan 2019 07:00 AM
RNS
RXC004 Trial Approval
10 Jan 2019 02:05 PM
RNS
Second Price Monitoring Extn
10 Jan 2019 02:00 PM
RNS
Price Monitoring Extension
03 Jan 2019 07:00 AM
RNS
Redx to present at 2019 Biotech Showcase event
28 Dec 2018 11:47 AM
RNS
Publication of Annual Report and Accounts
30 Nov 2018 08:45 AM
EQS
RedX Pharma (REDX): RXC006: First fibrosis deve...
30 Nov 2018 07:00 AM
RNS
First RXC006 data for treatment of fibrosis
27 Nov 2018 04:05 PM
EQS
Redx Pharma (REDX): Streamlined, focused and go...
19 Nov 2018 07:00 AM
RNS
CFO Announcement
19 Nov 2018 07:00 AM
RNS
Preliminary Results for year ended 30 Sept 2018
14 Nov 2018 07:00 AM
RNS
Redx announces new drug development candidate
09 Nov 2018 09:50 AM
EQS
Redx Pharma (REDX):ROCK2 inhibitors in chronic ...
05 Nov 2018 07:00 AM
RNS
Preclinical data presented at cancer conference
31 Oct 2018 07:00 AM
RNS
Notice of Results
UK 100

Latest directors dealings